Journal article
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial
Abstract
BACKGROUND: Embolic stroke of undetermined source (ESUS) identifies patients with cryptogenic ischemic stroke presumed due to embolism from several unidentified sources. Among patients with recent ESUS, we sought to determine independent predictors of recurrent ischemic stroke during treatment with aspirin or rivaroxaban and to assess the relative effects of these treatments according to risk.
METHODS: Exploratory analyses of 7213 participants …
Authors
Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D
Journal
Journal of Stroke and Cerebrovascular Diseases, Vol. 28, No. 8, pp. 2273–2279
Publisher
Elsevier
Publication Date
August 2019
DOI
10.1016/j.jstrokecerebrovasdis.2019.05.014
ISSN
1052-3057